Kappadione

Kappadione
Clinical data
Routes of; administration	Injection
ATC code	none;
Legal status
Legal status	US: Rx only, discontinued (was FDA Approved); In general: ℞ (Prescription only);
Identifiers
	IUPAC name Tetrasodium (2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate;
CAS Number	131-13-5 ; 6700-42-1 (hexahydrate);
PubChem CID	8555;
ChemSpider	8237 ;
UNII	2OVL75B30W;
CompTox Dashboard (EPA)	DTXSID80156832 ;
ECHA InfoCard	100.004.558
Chemical and physical data
Formula	C11H8Na4O8P2
Molar mass	422.084 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+];
	InChI InChI=1S/C11H12O8P2.4Na/c1-7-6-10(18-20(12,13)14)8-4-2-3-5-9(8)11(7)19-21(15,16)17;;;;/h2-6H,1H3,(H2,12,13,14)(H2,15,16,17);;;;/q;4*+1/p-4 ; Key:GZBACHSOZNEZOG-UHFFFAOYSA-J ;
	(what is this?) (verify)

Kappadione is a Vitamin K derivative. It was manufactured by Eli Lilly and Company.^[1] Chemically, it is menadiol sodium diphosphate.

References

^ "Kappadione overview, medicine.org". Archived from the original on 2016-03-03. Retrieved 2008-04-14.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.